Alemtuzumab-associated diffuse alveolar damage – a case report

BACKGROUND: Identifying causes of alemtuzumab induced respiratory symptoms in Multiple Sclerosis (MS) patients is crucial. CASE PRESENTATION: We report a case of diffuse alveolar damage (DAD) in a patient with MS after the first course of alemtuzumab treatment. A 42-year-old female developed progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayas, Antonios, Menacher, Martina, Schwaiblmair, Martin, Märkl, Bruno, Naumann, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510011/
https://www.ncbi.nlm.nih.gov/pubmed/32967641
http://dx.doi.org/10.1186/s12883-020-01934-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510011/
https://www.ncbi.nlm.nih.gov/pubmed/32967641
http://dx.doi.org/10.1186/s12883-020-01934-7

Ejemplares similares